Goldman Sachs Assumes Merck (MRK) at Buy

April 8, 2025 3:29 AM EDT Send to a Friend
Goldman Sachs analyst Asad Haider assumes coverage on Merck (NYSE: MRK) with a Buy rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login